1-(3-chlorophenyl)piperazine has been researched along with Chronic Disease in 2 studies
1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindenmayer, JP | 1 |
| Vital-Herne, M | 1 |
| Bark, N | 1 |
| Grochowski, S | 1 |
| Moynihan, N | 1 |
| Iqbal, N | 1 |
| Asnis, GM | 1 |
| Wetzler, S | 1 |
| Kahn, RS | 1 |
| Kay, SR | 1 |
| van Praag, HM | 1 |
2 trials available for 1-(3-chlorophenyl)piperazine and Chronic Disease
| Article | Year |
|---|---|
Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Female; Humans; Hydrocortisone; M | 1997 |
The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
Topics: Adult; Chronic Disease; Double-Blind Method; Humans; Hydrocortisone; Male; Piperazines; Prolactin; P | 1991 |